SUN — Surgical Innovations Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual income statement for Surgical Innovations, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11	10.7	6.33	9.13	11.3
Cost of Revenue
Gross Profit	4.67	4.33	1.27	3.13	3.92
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	10.3	13.2	9.5	9.58	11.3
Operating Profit	0.62	-2.44	-3.17	-0.455	0.041
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	0.515	-2.6	-3.31	-0.585	-0.057
Provision for Income Taxes
Net Income After Taxes	0.725	-2.62	-3.28	-0.456	0.264
Net Income Before Extraordinary Items
Net Income	0.725	-2.62	-3.28	-0.456	0.264
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	0.725	-2.62	-3.28	-0.456	0.264
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.001	-0.001	-0.003	-0	0